Semaglutide / Weight Loss Medication · Tool Face-Off

Ozempic vs Wegovy

Quick answer

Same molecule, different missions. Ozempic is FDA-approved for type 2 diabetes; Wegovy is FDA-approved for chronic weight management. Wegovy wins for weight loss due to its higher dose, but Ozempic is often prescribed off-label and is easier to find.

Ozempic

The diabetes drug that crashed the weight-loss party

3.6★

Our pick

Wegovy

Built for weight loss from the ground up

4.1★

Active Ingredient

Semaglutide

FDA-Approved Indication

Type 2 Diabetes

Chronic Weight Management

Max Weekly Dose

2 mg/week

2.4 mg/week

Average Weight Loss (Clinical Trials)

~6-7% body weight

~15% body weight

Dosing Steps

0.25 → 0.5 → 1 → 2 mg

0.25 → 0.5 → 1 → 1.7 → 2.4 mg

Injection Frequency

Once weekly

List Price (monthly, approx.)

~$900-$1,000/month

~$1,300-$1,400/month

Manufacturer Savings Card (eligible patients)

Up to $150/month off

Up to $225/month off

Supply Shortage History

Shortage ongoing (2022–present)

Improving but still constrained

Insurance Coverage (Weight Loss)

Rarely covered for weight loss

Some plans cover; still inconsistent

Cardiovascular Risk Reduction Approval

Yes (type 2 diabetes patients)

Yes (overweight/obese, SELECT trial 2024)

Compounded Generic Available

Yes (during shortage period)

Ozempic

Ease of Use★★★★½

Dosing Flexibility★★★½☆

Insurance Coverage★★★½☆

Side Effect Profile★★★★☆

Availability & Supply★★★½☆

Weight Loss Effectiveness★★★★☆

FDA Approval (Weight Loss)★★☆☆☆

Wegovy

Ease of Use★★★★½

Dosing Flexibility★★★★½

Insurance Coverage★★★½☆

Side Effect Profile★★★½☆

Availability & Supply★★★☆☆

Weight Loss Effectiveness★★★★★

FDA Approval (Weight Loss)★★★★★

Worth knowing

Wegovy's 2.4 mg dose is the highest approved semaglutide dose and was specifically studied for weight loss in the STEP trials.
Ozempic is frequently prescribed off-label for obesity, which contributes to supply shortages and frustrates diabetes patients who need it.
The SELECT trial (2024) gave Wegovy a major boost: it reduced cardiovascular events by ~20% in non-diabetic obese patients.
Both pens are pre-filled, once-weekly injections — the user experience is virtually identical.
Neither drug is intended to be used without lifestyle changes; diet and exercise still matter.
The FDA placed both on the drug shortage list, opening the door for compounding pharmacies — buyer beware on quality control.

Ozempic's jingle ('Oh-oh-oh Ozempic!') is legally a parody of a Pilot song from 1974 — and it did more for semaglutide awareness than any clinical trial ever could.

If you want

You want maximum weight loss with full FDA backing

Wegovy's 2.4 mg dose delivered ~15% body weight loss in trials — nearly double Ozempic's real-world average.

→ Pick Wegovy

If you want

You have type 2 diabetes AND want to lose weight

Ozempic is the on-label choice for T2D, and insurance is far more likely to cover it for that indication.

→ Pick Ozempic

If you want

You're worried about cardiovascular risk and are obese but not diabetic

Wegovy now has FDA approval for CV risk reduction in this exact population, backed by the landmark SELECT trial.

→ Pick Wegovy